All Title Author
Keywords Abstract

Enfermedad de Coats tratada con bevacizumab (Avastin?)

DOI: 10.4321/S0365-66912008000500010

Keywords: vascular endothelial growth factor, coats? disease, monoclonal antibodies, angiogenesis inhibitors, telangiectatic retinal vessels.

Full-Text   Cite this paper   Add to My Lib


case report: we report a case of coats? disease in a 10-year-old-girl who presented with a profound visual deficit, exudative retinal detachment, vascular telangiectasias and subretinal lipid, who underwent treatment with an intravitreal injection of bevacizumab (avastin?). serial examinations documented an involutional response with a reduction of the subretinal fluid, exudates and macular thickness. discussion: the aetiology of coats? disease remains uncertain, as does its optimal management. although resolution of a case depends partially on age, and can even occur spontaneously on rare occasions, intravitreal injections of bevacizumab should be considered when planning treatment.


comments powered by Disqus